Sorivudine

drugbox
width = 200
IUPAC_name = 5- [("E")-2-bromoethenyl] -1- [(2"R",3"S",4"S",5"R")-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl] pyrimidine-2,4-dione

---

synonyms = BV-araU,Bromovinyl araU,5-Bromovinyl-araU
CAS_number = 77181-69-2
ATC_prefix = J05
ATC_suffix = AB15
ATC_supplemental =
PubChem = 5282192
DrugBank =
C=11 | H=13 | Br=1 | N=2 | O=6
molecular_weight = 349.14 g/mol
melting_point =
bioavailability =
protein_bound =
metabolism = Viral thymidine kinase
elimination_half-life =
excretion = kidney
pregnancy_category =
legal_status =
routes_of_administration = oral

Sorivudine (INN) chemical name (E)-5-(2-Bromovinyl)- 1β-D-arabinofuranosyluracil, is a thymine analogue antiviral drug, marketed under trade names such as Usevir (Nippon Shoji,Eisai) and Brovavir (BMS).

Pharmacology

Feature

*First-line treatment of herpes drug acyclovir was (Zovirax, Activir) from VZV strong activity of the virus.
*Superior gastrointestinal absorption, absorption from the gastrointestinal tract after the most degrading without being excreted as urine.

Mechanism of action

*Sorivudine is phosphorylated by thymidine kinase activity in the body and is absorbed into the virus's DNA, to inhibit viral DNA replication of DNA polymerase to make it fail to inhibit viral growth.

Microbiology

Sorivudine is active against most species in the herpesvirus family.
*Herpes simplex virus type I (HSV-1)
*Varicella zoster virus (VZV)
*Epstein-Barr virus (EBV)